PMP: Treatment Considerations for Adult ADHD: Stimulants or Not, and if Yes, Which, How, and Why?
In this session, Stephanie Nichols, PharmD, BCPP, MPH will review adult ADHD and evidence-based medication treatment. First we will describe epidemiology and pathophysiology of adult ADHD. Next, we will compare and contrast medication treatment options for adult ADHD including stimulants and non-stimulant options. Finally, we will list treatment pearls for stimulant use including dose (mg), dosing (daily or not), and formulation strategies (eg. IR or ER); use in special populations (eg. older adults, or those with CV disease or SUD); and how/when to start, stop, combine, and switch treatments.
Learning Objectives:
- Describe epidemiology and pathophysiology of adult ADHD
- Compare and contrast medication treatment options for adult ADHD including stimulants and non-stimulant options
- List treatment pearls for stimulant use including dose (mg), dosing (daily or not), and formulation strategies (eg. IR or ER); use in special populations (eg. older adults, or those with CV disease or SUD); and how/when to start, stop, combine, and switch treatments.
Audience:
Prescribing Clinicians and their teams
Continuing Medical Education:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Hanley Center for Health Leadership and Education and CCSME. The Hanley Center for Health Leadership and Education is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
The Hanley Center for Health Leadership and Education designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
*Nurses and Nurse Practitioners will be awarded a certificate of participation with a maximum of 1 AMA PRA Category 1 Credit ™.
This course has been approved by Co-Occurring Collaborative Serving Maine (CCSME), as a NAADAC Approved Education Provider, for 1 educational credits. NAADAC Provider #324712, CCSME is responsible for all aspects of the programming.
Contact Hours 1 contact hours for social workers, licensed clinical professional counselors, and behavioral health professionals.
1 Category 1 Contact hours for psychologists. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.
1 contract hours CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission of Health Education Credentialing, Inc.
Speaker
-
Stephanie Vail PharmD BCPP MPH FCCP FAAPPStephanie Vail, PharmD, MPH, BCPP, FCCP, FAAPP is a Professor in the University of New England School of Pharmacy, Adjunct Clinical Assistant Professor of Psychiatry in the Tufts University School of Medicine, Core Faculty in the Maine Medical Center (MMC) Addiction Medicine Fellowship Program, and an Instructor in the MMC Psychiatry Residency Program. She is a Board-Certified Psychiatric Pharmacist (BCPP) with 20 years’ experience providing direct patient care and interprofessional teaching, including clinical precepting for over 200 pharmacy and medical students, residents, and fellows on the MMC psychiatry consult-liaison and addiction medicine services. She has been inducted as a Fellow of the American College of Clinical Pharmacists (FCCP) and the American Association of Psychiatric Pharmacists (FAAPP), and has co-authored over 40 publications in journals including Journal of Addiction Medicine, Pharmacotherapy, Current Psychiatry, Journal of Psychopharmacology, and Journal of Studies on Alcohol and Drugs. Outside of work, she enjoys spending time with her pups: Sage, Basil, & Penny, and being among trees. She also enjoys the ocean, yoga, reading non-fiction, gardening, watercolor painting, visiting lighthouses, and looking at the sky.
